United States Federal Circuit
Regeneron Pharmaceuticals, Inc. v. Merus N.V., 16-1346
Affirming the district court's ruling that the plaintiff in a patent infringement suit's patent was unenforceable due to their inequitable conduct during prosecution of the patent, namely the withholding of four references specifically to deceive the Patent and Trademark Office.
Appellate Information
- Published 2017/07/27
Judges
- PROST
Court
- United States Federal Circuit